Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT03874052 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Recurrent Acute Myeloid Leukemia
Recurrent Secondary Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
Refractory Secondary Acute Myeloid Leukemia

Interventions

DRUG: Azacitidine
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography Test
PROCEDURE: Punch Biopsy
OTHER: Questionnaire Administration
DRUG: Ruxolitinib
DRUG: Venetoclax

Sponsor

Jennifer Saultz

Collaborators

[object Object]
[object Object]
[object Object]